Electron beam melting (EBM) is an additive manufacturing approach, which permits forming custom-made implants that completely match the loss of the anatomical construction of bone. Implantation effectivity relies upon not solely on the implant’s purposeful or mechanical properties but in addition on its floor properties, that are of nice significance with regard to such organic processes as bone regeneration or microbial contamination. This work presents the influence of floor modifications (mechanical sprucing, sandblasting, and acid-polishing) of EBM-produced Ti6Al4V ELI implants on important organic parameters.
These embody wettability, cytotoxicity toward fibroblast and osteoblast cell line, and capability to type biofilm by Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans. Obtained outcomes indicated that every one ready surfaces exhibited hydrophilic character and the very best adjustments of wettability have been obtained by chemical modification.
All implants displayed no cytotoxicity towards osteoblast and fibroblast cell strains regardless of the modification sort. In flip, the quantitative microbiological assessments and visualization of microbial biofilm by means of electron microscopy confirmed that sort of implant’s modification correlated with the species-specific capability of microbes to type biofilm on it. Thus, the outcomes of the introduced examine verify the connection between such technological facets as floor modification and organic properties. The offered knowledge are helpful with regard to functions of the EBM expertise and current a big step in direction of customized, custom-made implantology observe.
Effects of Postprocess Hot Isostatic Pressing Treatments on the Mechanical Performance of EBM Fabricated TI-6Al-2Sn-4Zr-2Mo
An basically totally acicular alpha-prime martensite inside an equiaxed grain construction was produced in an Electron Beam Melting (EBM)-fabricated Ti-6Al-2Sn-4Zr-2Mo (Ti6242) alloy utilizing two completely different Arcam EBM machines: An A2X system using tungsten filament thermionic electron emission, and a Q20 system using LaB6 thermionic electron emission.
Post-process Hot Isostatic Pressing (HIP) therapy for two h at 850, 950, and 1050 °C resulted in grain refinement and equiaxed grain progress together with alpha-prime martensite decomposition to type an intragranular combination of acicular martensite and alpha at 850 °C, and acicular alpha part at 950 and 150 °C, usually exhibiting a Widmanstätten (basketweave) construction.
The corresponding tensile yield stress and final tensile power (UTS) related to the grain progress and acicular alpha evolution decreased from ~1 and ~1.1 GPa, respectively, for the as-fabricated Ti6242 alloy to ~0.8 and 0.9 GPa, respectively, for HIP at 1050 °C. The optimum elongation of ~15-16% occurred for HIP at 850 °C; for each EBM techniques. Because of the interactive position performed by equiaxed grain progress and the intragrain, acicular alpha microstructures, the hardness diverse solely by ~7% between 41 and 38 HRC.
GP trainees’ perceptions on studying EBM utilizing conversations within the office: a video-stimulated interview examine.
To be capable to observe evidence-based medication (EBM) when making selections for particular person sufferers, it is very important discover ways to mix the most effective accessible proof with the affected person’s preferences and the doctor’s scientific experience. In normal observe coaching, these abilities might be discovered on the office utilizing studying conversations: conferences between the supervising normal practitioner (GP) and GP trainee to debate medical observe, chosen subjects or skilled efficiency.
This examine aimed to offer perception into the perceptions of GP trainees on their EBM studying processes throughout studying conversations.We held semi-structured video-stimulated elicitation interviews (n = 22) with GP trainees affiliated to GP coaching institutes within the Netherlands and Belgium. GP trainees have been proven fragments of their studying conversations, enabling reflection throughout the interview. Taking an inductive strategy, interview recordings have been transcribed verbatim and analysed with NVivo software program.GP trainees perceived studying conversations as helpful for studying and discussing EBM.
Multiple EBM studying actions have been recognized, comparable to discussing proof collectively, relating proof to instances in every day observe and discussing the supervisor’s expertise and the particular native context within the mild of what the proof recommends. However, for studying to happen, trainees want and anticipate particular behaviour, each from their supervisors and themselves. Supervisors ought to provide well-substantiated solutions which can be relevant in observe and give the trainee affirmation.
In flip, the trainee wants to organize effectively as a way to ask centered, in-depth questions. A protected area permitting equal and open dialogue between trainee and supervisor is perceived as an important context for optimum EBM studying.Our findings present that trainees discover studying conversations helpful for EBM studying generally observe. To deliver EBM studying to its full potential, consideration needs to be paid to optimising the behavioural and contextual elements discovered related to enhancing EBM studying.
Application of effect-based strategies (EBMs) in a river basin: a preliminary examine in Central Italy.
Effect-based strategies (EBMs), i.e. in vitro and in vivo bioassays, symbolize revolutionary instruments for the impact detection of environmental chemical pollution on residing organisms. The goal of this examine was to judge the water high quality of a river ecosystem implementing two in vivo bioassays on goal freshwater animal species: the crustacean Daphnia magna and the small fish Danio rerio, also called zebrafish.The strategies utilized on this examine, i.e. the Daphnia sp. Acute Immobilisation assay and the Fish Embryo Acute Toxicity (FET) check, are generally utilized in water high quality analysis and their software in short-term ecotoxicity detection is recommended by current European tasks.
Two sampling websites have been chosen within the city half of the Tiber River in Rome, whereas a 3rd one was chosen as a reference website within the Farfa River, a tributary upstream of the town. The websites within the Tiber River are probably affected by completely different air pollution sources, together with city and industrial wastewater discharges, the pesticide launch, livestock waste merchandise, and waste dumps.
The outcomes of the examine confirmed huge variations between the 2 utilized bioassays. The FET check was usually extra delicate in detecting even low results in all of the water samples, however the strongest statistically outcomes have been noticed with the D. magna Acute Immobilisation check.
The outcomes of this analysis verify the effectiveness of EBMs in investigating and monitoring water chemical air pollution, and stress the necessity for performing additional research, e.g. chemical analyses and different bioassays, to enhance the information of the well being standing of the Tiber River basin.
SIRT CRISPR Knock Out Human HepG2 Cell Line - Clone T3-6 |
T6804 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
CXCL8 CRISPR Knock Out L3.6pl Cell Line |
T6220 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
CXCL1 CRISPR Knock Out L3.6pl Cell Line |
T6221 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
Ccl2 CRISPR Knock Out CT26 Cell Line |
T9611 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
TRPV6 CRISPR Knock Out Human PC3-M Cell Line |
T6219 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
FOLR CRISPR Knock Out Human OVCAR3-A1 Cell Line |
T6229 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
MUC16 CRISPR Knock Out Human OVCAR3-A1 Cell Line |
T6230 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
NR2F6 CRISPR Knock Out Human Jurkat E6.1 Cell Line - Clone T3-10 |
T6822 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
Aldh2 CRISPR Knock Out L929 Cell Line - Clone T3-20 |
T9692 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
TREM2 CRISPR Knock Out Human THP-1 Cell Line - Clone T1-9 |
T6810 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
PTPN6 CRISPR Knock Out Human THP-1 Cell Line - Clone T3-1 |
T6813 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
PTPN11 CRISPR Knock Out NIH/3T3 Cell Line - Clone T4-9 |
T6803 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
METTL3 CRISPR Knock Out Caki-1 Cell Line - Clone T2-16 |
T9623 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
Nacc1 CRISPR Knock Out ID8 Cell Line (Mouse) - Clone T1-23 |
T9627 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
osbpl2 CRISPR Knock Out NIH/3T3 Cell Line - T1 Polyclonal Pool |
T9682 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
GLT1 CRISPR Knock Out Rat AST Cell Line - Clone T2-1 |
T9678 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
PRSS21 CRISPR Knock Out Human OVCAR8 Cell Line - Clone T2 C8 |
T6811 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
SEC61G CRISPR Knock Out HCC-LM3 Cell Line - Clone T2-17-5 |
T9746 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
Aifm1 CRISPR Knock Out Mouse L929 Cell Line - Clone T2-15-3 |
T9674 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
MSLN CRISPR Knock Out Human OVCAR3-A1 Cell Line - Clone T2 C4 |
T6820 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
CARMIL1 CRISPR Knock Out Immortalized Human Gingival Fibroblast - hTERT Cell Line - T1-2 |
T6825 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
hPIM1 CRISPR Knock Out SACC-83 Cell Line-T3-9 |
T9787 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
Dcx CRISPR Knock Out C6 Cell Line (Rat) - Clone sg4-1 |
T9624 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
Cell line gene knock-in and knock-out |
S301 |
101Bio |
- |
EUR 15000 |
SIRT1 Knockout Stable 293T Cell Line |
T3176 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
Araf CRISPR Knocked out RAW264.7 Stable cell Cell Line (Mouse) T1-19 |
T9511 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
Araf CRISPR Knocked out RAW264.7 Stable cell Cell Line (Mouse) T3-3 |
T9529 |
ABM |
1x10^6 cells/1.0ml |
EUR 3950 |
T47D/GFP Cell Line |
AKR-208 |
Cell Biolabs |
1 vial |
EUR 686.4 |
Description: T47D/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
Stable Mouse Myeloid-derived Suppressor-like LAL Knock Out (HD1B) Cell Line |
T3187 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
293T [HEK-293T] Cell Line |
CL-0005 |
Elabscience Biotech |
1×10⁶ cells/vial |
EUR 420 |
|
Description: Homo sapiens, Human |
293T Cell Line |
LV010 |
ABM |
1x10^6 |
EUR 450 |
293T/17 Cell Line |
CL-0469 |
Elabscience Biotech |
1×10⁶ cells/vial |
EUR 500 |
|
Description: Homo sapiens, Human |
293T Cell Lysate (Human embryonic kidney cell line) |
LF-R0006 |
Abfrontier |
200 ul |
EUR 103.2 |
Description: 293T (Human embryonic kidney cell line) Whole Cell Lysate |
293AD Cell Line |
AD-100 |
Cell Biolabs |
1 vial |
EUR 553.2 |
Description: The 293AD Cell Line is derived from the parental 293 cells but selected for attributes that increase adenovirus production, including firmer attachment and larger surface area. |
293AAV Cell Line |
AAV-100 |
Cell Biolabs |
1 vial |
EUR 609.6 |
Description: The 293AAV Cell Line is derived from the parental 293 cells but selected for attributes that increase AAV production, including firmer attachment and larger surface area. |
293LTV Cell Line |
LTV-100 |
Cell Biolabs |
1 vial |
EUR 609.6 |
Description: The 293LTV Cell Line is derived from the parental 293 cells but selected for attributes that increase lentiviral production, including fimrer attachment and larger surface area. |
293RTV Cell Line |
RV-100 |
Cell Biolabs |
1 vial |
EUR 609.6 |
Description: The 293RTV Cell Line is derived from the parental 293 cells but selected for attributes that increase retroviral production, including fimrer attachment and larger surface area. |
Cas9 Expressing 293T Cell Line |
T3251 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 795 |
293/GFP Cell Line |
AKR-200 |
Cell Biolabs |
1 vial |
EUR 686.4 |
Description: 293/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
A549/GFP Cell Line |
AKR-209 |
Cell Biolabs |
1 vial |
EUR 686.4 |
Description: A549/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
HeLa/GFP Cell Line |
AKR-213 |
Cell Biolabs |
1 vial |
EUR 686.4 |
Description: HeLa/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
NIH3T3/GFP Cell Line |
AKR-214 |
Cell Biolabs |
1 vial |
EUR 686.4 |
Description: NIH3T3/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
NIH3T3/Cas9 Cell Line |
AKR-5104 |
Cell Biolabs |
1 vial |
EUR 686.4 |
Blank Promoter Stable Expressing Human 293T Cell Line |
T9618 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
MCF-7/Luc Cell Line |
AKR-234 |
Cell Biolabs |
1 vial |
EUR 686.4 |
Description: MCF-7/Luc Cell Line stably expresses luciferase and otherwise exhibits the same characteristics of the parental cell line. |
SKOV-3/Luc Cell Line |
AKR-232 |
Cell Biolabs |
1 vial |
EUR 686.4 |
Description: SKOV-3/Luc Cell Line stably expresses luciferase and otherwise exhibits the same characteristics of the parental cell line. |
Stable 293T-ATD cell line |
T6340 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
OVCAR-5/RFP Cell Line |
AKR-254 |
Cell Biolabs |
1 vial |
EUR 686.4 |
Description: OVCAR-5/RFP Cell Line stably expresses RFP and otherwise exhibits the same characteristics of the parental cell line. |
PTPN6 Stable Knocked Out THP-1 Cell Line |
T6216 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
SIRT1 Wildtype Stable 293T Cell Line |
T3175 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
Mouse NACC1 CRISPR Stable Knockout ID8 Cell Line - Clone T1-23 |
T6826 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
PGC-1α/ERRα Stable 293T Cell Line |
T3060 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 385 |
Platinum-E Retroviral Packaging Cell Line, Ecotropic |
RV-101 |
Cell Biolabs |
1 vial |
EUR 1104 |
Description: Conventional cells used for retrovirus packaging, such as those based on NIH3T3 cells, have limited stability and produce relatively low yields of retrovirus, mainly due to the poor expression of retroviral structure proteins (gag, pol and env) in the cells. The Platinum Retroviral Packaging Cell Lines are based on the 293T cell line. They exhibit longer stability and produce higher yields of retroviral structure proteins. Plat-E cells contain gag, pol and env genes, allowing retroviral packaging with a single plasmid transfection. |
Platinum-GP Retroviral Packaging Cell Line, Pantropic |
RV-103 |
Cell Biolabs |
1 vial |
EUR 1104 |
Description: Conventional cells used for retrovirus packaging, such as those based on NIH3T3 cells, have limited stability and produce relatively low yields of retrovirus, mainly due to the poor expression of retroviral structure proteins (gag, pol and env) in the cells. The Platinum Retroviral Packaging Cell Lines are based on the 293T cell line. They exhibit longer stability and produce higher yields of retroviral structure proteins. Plat-GP cells contain the gag and pol genes required for retroviral packaging; an expression vector is co-transfected with a VSVG envelope vector. |
Platinum-A Retroviral Packaging Cell Line, Amphotropic |
RV-102 |
Cell Biolabs |
1 vial |
EUR 1104 |
Description: Conventional cells used for retrovirus packaging, such as those based on NIH3T3 cells, have limited stability and produce relatively low yields of retrovirus, mainly due to the poor expression of retroviral structure proteins (gag, pol and env) in the cells. The Platinum Retroviral Packaging Cell Lines are based on the 293T cell line. They exhibit longer stability and produce higher yields of retroviral structure proteins. Plat-A cells contain gag, pol and env genes, allowing retroviral packaging with a single plasmid transfection. |
Total Protein - Murine Embryonic Stem Cell Line D3 |
CBA-305 |
Cell Biolabs |
500 ?g |
EUR 414 |
Description: - Isolated from mouse ES-D3 cell line
- Presented as 500 µg at 1 mg/mL in NP-40 Solubilization Buffer
|
Mouse R-spondin1 Stable 293T Cell Line |
T3156 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
PFN2 Stable Expressing 293T Cell Line - Polyclonal |
T9606 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
TARGATT? Knock-in Mouse Cell Line Generation Kit (Master Cell Line) |
AST-7001 |
Applied StemCell |
1 Kit |
Ask for price |
Description: 6 month |
BRCA1 CRISPR Stable Knockout Human Fibroblast Cell Line |
T6245 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
Human 293T Cell Lysate Lyophilized |
IHU293TTLLY200UG |
Innovative research |
each |
EUR 89 |
|
Description: Human 293T Cell Lysate Lyophilized |
EBM 3'UTR GFP Stable Cell Line |
TU056522 |
ABM |
1.0 ml |
EUR 2799.6 |
TARGATT? Knock-in iPSC Generation (Master Cell Line) |
AST-1100 |
Applied StemCell |
1 vial of 1X10^6 cells |
Ask for price |
Description: 6 month |
YBX1 Stable Knockout Human NK/T Cell Line #T3-16 P6 |
T9508 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
Human CRISP1 knockout cell line |
ABC-KH3569 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRISP1 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CRISP2 knockout cell line |
ABC-KH3570 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRISP2 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CRISP3 knockout cell line |
ABC-KH3571 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRISP3 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
PTPRA CRISPR Knockout Immortalized Human Lung Fibroblast Cell Line |
T6827 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
Human 293T Whole Cell Lysate |
LYSATE0032 |
BosterBio |
200ug |
EUR 180 |
Description: This cell lysate is prepared from human 293T using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
EBM 3'UTR Luciferase Stable Cell Line |
TU006522 |
ABM |
1.0 ml |
EUR 2799.6 |
VEGF Promoter Stable Expressing 293T Cell Line - Clone #2 |
T9622 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
Human CRISPLD1 knockout cell line |
ABC-KH3572 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRISPLD1 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CRISPLD2 knockout cell line |
ABC-KH3573 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRISPLD2 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
AAVS1 Positive Control EGIP 293T Reporter Cell Line |
CAS606A-1 |
SBI |
1 Vial |
EUR 726 |
Acan CRISPR Knockout RCS Cell Line (Rat) |
T3000 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
TARGATT? Knock-in CHO Generation Kit (Master Cell Line) |
AST-1200 |
Applied StemCell |
1 Kit |
Ask for price |
Description: 12 month |
Human CRISP1 knockdown cell line |
ABC-KD3569 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRISP1 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Human CRISP2 knockdown cell line |
ABC-KD3570 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRISP2 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Human CRISP3 knockdown cell line |
ABC-KD3571 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRISP3 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
TARGATT? Knock-in HEK293 Generation Kit (Master Cell Line) |
AST-1300 |
Applied StemCell |
1 Kit |
Ask for price |
Description: 12 month |
Human CRISPLD1 knockdown cell line |
ABC-KD3572 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRISPLD1 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Human CRISPLD2 knockdown cell line |
ABC-KD3573 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRISPLD2 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
GFAT1 CRISPR Stable Knockout H1299 Cell Line |
T6199 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
EDC4 CRISPR Stable Knockout HEK293T Cell Line |
T6241 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
DJ-1 CRISPR Stable Knockout HeLa Cell Line |
T6181 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
EBM sgRNA CRISPR Lentivector set (Human) |
K0650101 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
PD-L1 CRISPR Stable Knockout CT26 Cell Line |
T6237 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
PDPN CRISPR Stable Knockout COS-7 Cell Line |
T6039 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
PD-L1 CRISPR Stable Knockout MC38 Cell Line |
T6149 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
LIMD1-/- CRISPR Stable Knockout HeLa Cell Line |
T6357 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
SLC35A1 CRISPR Stable Knockout CHO-S Cell Line |
T6040 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
CXCL1 & CXCL8 CRISPR Double Knockout L3.6pl Cell Line |
T6047 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
hCETP shRNA (Target C) Knock Down THP-1 Cell Line-Polyclone |
T9789 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
AXL CRISPR Stable Knockout HT1080 (1-IV) Cell Line |
T6232 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
AXL CRISPR Stable Knockout HT1080 (3-II) Cell Line |
T6233 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
Human CRIM1 knockout cell line |
ABC-KH3563 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRIM1 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CRIP1 knockout cell line |
ABC-KH3564 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRIP1 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CRIP2 knockout cell line |
ABC-KH3565 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRIP2 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CRIP3 knockout cell line |
ABC-KH3566 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRIP3 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CRIPT knockout cell line |
ABC-KH3568 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRIPT knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CRIPAK knockout cell line |
ABC-KH3567 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRIPAK knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
EBM sgRNA CRISPR Lentivector (Human) (Target 1) |
K0650102 |
ABM |
1.0 ug DNA |
EUR 184.8 |
EBM sgRNA CRISPR Lentivector (Human) (Target 2) |
K0650103 |
ABM |
1.0 ug DNA |
EUR 184.8 |
EBM sgRNA CRISPR Lentivector (Human) (Target 3) |
K0650104 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Cas9 (CRISPR Associated Protein 9) ELISA Kit |
PRB-5079 |
Cell Biolabs |
96 assays |
EUR 686.4 |
Cas13a (CRISPR Associated Protein 13a, C2c2) ELISA Kit |
PRB-5091 |
Cell Biolabs |
96 assays |
EUR 686.4 |
CytoSelect Cell Transformation Assay (Cell Recovery Compatible), Colorimetric |
CBA-135 |
Cell Biolabs |
96 assays |
EUR 985.2 |
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis. |
CytoSelect Cell Transformation Assay (Cell Recovery Compatible), Colorimetric |
CBA-135-5 |
Cell Biolabs |
5 x 96 assays |
EUR 4027.2 |
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis. |
CytoSelect Cell Transformation Assay (Cell Recovery Compatible), Fluorometric |
CBA-140 |
Cell Biolabs |
96 assays |
EUR 1027.2 |
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis. |
CytoSelect Cell Transformation Assay (Cell Recovery Compatible), Fluorometric |
CBA-140-5 |
Cell Biolabs |
5 x 96 assays |
EUR 4179.6 |
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis. |
StemTAG Stem Cell Colony Formation Assay (Cell Recovery Compatible) |
CBA-325 |
Cell Biolabs |
96 assays |
EUR 1027.2 |
Description: Our StemTAG 96-Well Stem Cell Colony Formation Assay provides a high-throughput method to quantify ES cells in just 7-10 days, and no manual cell counting is required. Once colonies are formed, they may be analyzed in three different ways: 1. Lyse cells, then quantify in a fluorescence plate reader using dye included in the kit; 2. Lyse cells, then quantify alkaline phosphatase activity using reagents provided; or 3. Recover colonies from matrix for further culture or analysis. |
StemTAG Stem Cell Colony Formation Assay (Cell Recovery Compatible) |
CBA-325-5 |
Cell Biolabs |
5 x 96 assays |
EUR 4033.2 |
Description: Our StemTAG 96-Well Stem Cell Colony Formation Assay provides a high-throughput method to quantify ES cells in just 7-10 days, and no manual cell counting is required. Once colonies are formed, they may be analyzed in three different ways: 1. Lyse cells, then quantify in a fluorescence plate reader using dye included in the kit; 2. Lyse cells, then quantify alkaline phosphatase activity using reagents provided; or 3. Recover colonies from matrix for further culture or analysis. |
Human CRIM1 knockdown cell line |
ABC-KD3563 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRIM1 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Human CRIP1 knockdown cell line |
ABC-KD3564 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRIP1 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Human CRIP2 knockdown cell line |
ABC-KD3565 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRIP2 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Human CRIP3 knockdown cell line |
ABC-KD3566 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRIP3 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Human CRIPT knockdown cell line |
ABC-KD3568 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRIPT knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Human CRIPAK knockdown cell line |
ABC-KD3567 |
AcceGen |
1 vial |
Ask for price |
Description: Human CRIPAK knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Human LIN37 knockout cell line |
ABC-KH8476 |
AcceGen |
1 vial |
Ask for price |
Description: Human LIN37 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human KY knockout cell line |
ABC-KH8250 |
AcceGen |
1 vial |
Ask for price |
Description: Human KY knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human MB knockout cell line |
ABC-KH9065 |
AcceGen |
1 vial |
Ask for price |
Description: Human MB knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human F2 knockout cell line |
ABC-KH5009 |
AcceGen |
1 vial |
Ask for price |
Description: Human F2 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human F3 knockout cell line |
ABC-KH5014 |
AcceGen |
1 vial |
Ask for price |
Description: Human F3 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human F5 knockout cell line |
ABC-KH5015 |
AcceGen |
1 vial |
Ask for price |
Description: Human F5 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human F7 knockout cell line |
ABC-KH5016 |
AcceGen |
1 vial |
Ask for price |
Description: Human F7 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human F8 knockout cell line |
ABC-KH5017 |
AcceGen |
1 vial |
Ask for price |
Description: Human F8 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human F9 knockout cell line |
ABC-KH5021 |
AcceGen |
1 vial |
Ask for price |
Description: Human F9 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GC knockout cell line |
ABC-KH5948 |
AcceGen |
1 vial |
Ask for price |
Description: Human GC knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human GK knockout cell line |
ABC-KH6087 |
AcceGen |
1 vial |
Ask for price |
Description: Human GK knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human HP knockout cell line |
ABC-KH6972 |
AcceGen |
1 vial |
Ask for price |
Description: Human HP knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human HR knockout cell line |
ABC-KH6992 |
AcceGen |
1 vial |
Ask for price |
Description: Human HR knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human C2 knockout cell line |
ABC-KH1951 |
AcceGen |
1 vial |
Ask for price |
Description: Human C2 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human C3 knockout cell line |
ABC-KH2027 |
AcceGen |
1 vial |
Ask for price |
Description: Human C3 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human C5 knockout cell line |
ABC-KH2074 |
AcceGen |
1 vial |
Ask for price |
Description: Human C5 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human C6 knockout cell line |
ABC-KH2100 |
AcceGen |
1 vial |
Ask for price |
Description: Human C6 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human C7 knockout cell line |
ABC-KH2130 |
AcceGen |
1 vial |
Ask for price |
Description: Human C7 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human C9 knockout cell line |
ABC-KH2174 |
AcceGen |
1 vial |
Ask for price |
Description: Human C9 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CP knockout cell line |
ABC-KH3480 |
AcceGen |
1 vial |
Ask for price |
Description: Human CP knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CS knockout cell line |
ABC-KH3611 |
AcceGen |
1 vial |
Ask for price |
Description: Human CS knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human KL knockout cell line |
ABC-KH7942 |
AcceGen |
1 vial |
Ask for price |
Description: Human KL knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human SI knockout cell line |
ABC-KH13776 |
AcceGen |
1 vial |
Ask for price |
Description: Human SI knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human T knockout cell line |
ABC-KH15011 |
AcceGen |
1 vial |
Ask for price |
Description: Human T knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human TF knockout cell line |
ABC-KH15318 |
AcceGen |
1 vial |
Ask for price |
Description: Human TF knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human TG knockout cell line |
ABC-KH15342 |
AcceGen |
1 vial |
Ask for price |
Description: Human TG knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human TH knockout cell line |
ABC-KH15368 |
AcceGen |
1 vial |
Ask for price |
Description: Human TH knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human AR knockout cell line |
ABC-KH0856 |
AcceGen |
1 vial |
Ask for price |
Description: Human AR knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human PC knockout cell line |
ABC-KH11173 |
AcceGen |
1 vial |
Ask for price |
Description: Human PC knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human XG knockout cell line |
ABC-KH17067 |
AcceGen |
1 vial |
Ask for price |
Description: Human XG knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human XK knockout cell line |
ABC-KH17074 |
AcceGen |
1 vial |
Ask for price |
Description: Human XK knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CEL knockout cell line |
ABC-KH2905 |
AcceGen |
1 vial |
Ask for price |
Description: Human CEL knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LINS knockout cell line |
ABC-KH8486 |
AcceGen |
1 vial |
Ask for price |
Description: Human LINS knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LIN7A knockout cell line |
ABC-KH8477 |
AcceGen |
1 vial |
Ask for price |
Description: Human LIN7A knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LIN7B knockout cell line |
ABC-KH8478 |
AcceGen |
1 vial |
Ask for price |
Description: Human LIN7B knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LIN7C knockout cell line |
ABC-KH8479 |
AcceGen |
1 vial |
Ask for price |
Description: Human LIN7C knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LIN28A knockout cell line |
ABC-KH8474 |
AcceGen |
1 vial |
Ask for price |
Description: Human LIN28A knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LIN28B knockout cell line |
ABC-KH8475 |
AcceGen |
1 vial |
Ask for price |
Description: Human LIN28B knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LAT knockout cell line |
ABC-KH8305 |
AcceGen |
1 vial |
Ask for price |
Description: Human LAT knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LBH knockout cell line |
ABC-KH8311 |
AcceGen |
1 vial |
Ask for price |
Description: Human LBH knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LBP knockout cell line |
ABC-KH8312 |
AcceGen |
1 vial |
Ask for price |
Description: Human LBP knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LBR knockout cell line |
ABC-KH8313 |
AcceGen |
1 vial |
Ask for price |
Description: Human LBR knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LCK knockout cell line |
ABC-KH8337 |
AcceGen |
1 vial |
Ask for price |
Description: Human LCK knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LCT knockout cell line |
ABC-KH8354 |
AcceGen |
1 vial |
Ask for price |
Description: Human LCT knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LEP knockout cell line |
ABC-KH8386 |
AcceGen |
1 vial |
Ask for price |
Description: Human LEP knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LHB knockout cell line |
ABC-KH8423 |
AcceGen |
1 vial |
Ask for price |
Description: Human LHB knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LIF knockout cell line |
ABC-KH8441 |
AcceGen |
1 vial |
Ask for price |
Description: Human LIF knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LOR knockout cell line |
ABC-KH8599 |
AcceGen |
1 vial |
Ask for price |
Description: Human LOR knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LOX knockout cell line |
ABC-KH8600 |
AcceGen |
1 vial |
Ask for price |
Description: Human LOX knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LPA knockout cell line |
ABC-KH8606 |
AcceGen |
1 vial |
Ask for price |
Description: Human LPA knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LPL knockout cell line |
ABC-KH8624 |
AcceGen |
1 vial |
Ask for price |
Description: Human LPL knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LPO knockout cell line |
ABC-KH8625 |
AcceGen |
1 vial |
Ask for price |
Description: Human LPO knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LPP knockout cell line |
ABC-KH8626 |
AcceGen |
1 vial |
Ask for price |
Description: Human LPP knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LSR knockout cell line |
ABC-KH8770 |
AcceGen |
1 vial |
Ask for price |
Description: Human LSR knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LSS knockout cell line |
ABC-KH8771 |
AcceGen |
1 vial |
Ask for price |
Description: Human LSS knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LTA knockout cell line |
ABC-KH8773 |
AcceGen |
1 vial |
Ask for price |
Description: Human LTA knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LTB knockout cell line |
ABC-KH8775 |
AcceGen |
1 vial |
Ask for price |
Description: Human LTB knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LTF knockout cell line |
ABC-KH8784 |
AcceGen |
1 vial |
Ask for price |
Description: Human LTF knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LTK knockout cell line |
ABC-KH8785 |
AcceGen |
1 vial |
Ask for price |
Description: Human LTK knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LUM knockout cell line |
ABC-KH8789 |
AcceGen |
1 vial |
Ask for price |
Description: Human LUM knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LXN knockout cell line |
ABC-KH8796 |
AcceGen |
1 vial |
Ask for price |
Description: Human LXN knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LY9 knockout cell line |
ABC-KH8809 |
AcceGen |
1 vial |
Ask for price |
Description: Human LY9 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LYN knockout cell line |
ABC-KH8815 |
AcceGen |
1 vial |
Ask for price |
Description: Human LYN knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human LYZ knockout cell line |
ABC-KH8839 |
AcceGen |
1 vial |
Ask for price |
Description: Human LYZ knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human MAF knockout cell line |
ABC-KH8868 |
AcceGen |
1 vial |
Ask for price |
Description: Human MAF knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human MAG knockout cell line |
ABC-KH8875 |
AcceGen |
1 vial |
Ask for price |
Description: Human MAG knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human MAK knockout cell line |
ABC-KH8917 |
AcceGen |
1 vial |
Ask for price |
Description: Human MAK knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human MAL knockout cell line |
ABC-KH8918 |
AcceGen |
1 vial |
Ask for price |
Description: Human MAL knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human MAZ knockout cell line |
ABC-KH9064 |
AcceGen |
1 vial |
Ask for price |
Description: Human MAZ knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human MBP knockout cell line |
ABC-KH9091 |
AcceGen |
1 vial |
Ask for price |
Description: Human MBP knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human MCC knockout cell line |
ABC-KH9102 |
AcceGen |
1 vial |
Ask for price |
Description: Human MCC knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human MCU knockout cell line |
ABC-KH9124 |
AcceGen |
1 vial |
Ask for price |
Description: Human MCU knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human MDK knockout cell line |
ABC-KH9134 |
AcceGen |
1 vial |
Ask for price |
Description: Human MDK knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human ME1 knockout cell line |
ABC-KH9138 |
AcceGen |
1 vial |
Ask for price |
Description: Human ME1 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human ME2 knockout cell line |
ABC-KH9139 |
AcceGen |
1 vial |
Ask for price |
Description: Human ME2 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human ME3 knockout cell line |
ABC-KH9140 |
AcceGen |
1 vial |
Ask for price |
Description: Human ME3 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Further outcomes will goal to help the native authorities in adopting measures to scale back and to remove the sources of chemical air pollution within the examine space.